Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study

BACKGROUND: The feasibility of drug monitoring of serum concentrations of morphine, morphine-6-glucuronide (M6G) and morphine-3-glucuronide (M3G) during chronic morphine therapy is not established. One important factor relevant to drug monitoring is to what extent morphine, M6G and M3G serum concent...

Descripción completa

Detalles Bibliográficos
Autores principales: Klepstad, Pål, Hilton, Priscilla, Moen, Jorunn, Kaasa, Stein, Borchgrevink, Petter C, Zahlsen, Kolbjørn, Dale, Ola
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526195/
https://www.ncbi.nlm.nih.gov/pubmed/15461818
http://dx.doi.org/10.1186/1472-6904-4-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526195/
https://www.ncbi.nlm.nih.gov/pubmed/15461818
http://dx.doi.org/10.1186/1472-6904-4-7

Ejemplares similares